Takeda

Idebenone, an antioxidant and possible cellular energy booster, will be tested in some 240 boys with DMD

posted on October 8, 2009 - 10:27am
This story was updated 11/9/10 with contact information for this trial and information about clinical trials in general. Pediatric Neurologist Richard Finkel, co-director of the MDA neuromuscular disease clinic at Children's Hospital of Philadelphia, will be the lead investigator for the North American arm of a large international trial with idebenone in Duchenne muscular dystrophy (DMD).

New content is being added every day. Please check back again.